WS1-2-4 Phase I Clinical Study of Anti-apoptosis Protein, Survivin-derived Peptide Vaccine Therapy for Patients with Advanced or Recurrent Urothelial Cancer(Urothelial Cell Cancer)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.